Belo, Rufino G.
HRN: 21-13-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/22/2024
06/28/2024
IV
2.25 Grams
Q 6 Hrs
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes